Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel isoserine ester derivates and method for preparing same

An isoserine ester and acidic technology, which is applied in the field of preparing the anti-tumor drug docetaxel, can solve the problems of low yield, high price, and difficult separation, and achieve the effect of high yield and easy operation

Inactive Publication Date: 2008-10-22
SHANGHAI TECHWELL BIOPHARMACEUTICALS CO LTD
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] 1. The condensation yield of taxane core and side chain is not high, the condensation products are complex and difficult to separate
[0018] 2. In the process of further preparing docetaxel from the obtained condensation product, the yield is low and the operation steps are many
[0025] In addition, because 10-deacetylbaccatin (III) comes from natural extraction, the source is limited, and the price is high, so the condensation yield and subsequent reaction yield have a great impact on the cost of docetaxel, which is urgently needed in this field. It is necessary to explore new docetaxel synthesis methods and intermediates to improve the yield of docetaxel synthesis, simplify and optimize the synthesis process of docetaxel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel isoserine ester derivates and method for preparing same
  • Novel isoserine ester derivates and method for preparing same
  • Novel isoserine ester derivates and method for preparing same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0130] Example 1: Preparation of 2'-triethylsilyl-7,10-bis(trichloroacetyl)docetaxel

[0131] 7,10-bis(trichloroacetyl)baccatin (III) (20 g) was dissolved in THF, under nitrogen protection, the temperature was lowered to -65°C, 1.5N lithium bis(trimethylsilyl)amide was added dropwise, Then 1-tert-butoxycarbonyl-3-triethylsilyloxy-4-phenyl-azetidinone tetrahydrofuran solution (21 g, 100 ml) was added dropwise, the temperature was raised to -50° C., and the reaction was carried out for 40 min. Saturated brine (600ml) was added, and the aqueous layer was extracted with ethyl acetate (400ml×2). The organic layer was washed with water (300ml) and saturated brine (300ml), dried over anhydrous sodium sulfate, concentrated to dryness, and then dissolved in ethyl acetate and The product was crystallized in n-hexane mixture to obtain 28 g (yield 95%).

[0132] MS (m / z): 1232 (M+Na). 1 HNMR (500MHz) δ0.45(6H, t), 0.81(9H, m), 1.14(3H, s), 1.24(2H, m), 1.37(9H, s), 1.69(3H, s), 1.73( 2...

Embodiment 2

[0133] Example 2: Preparation of docetaxel from 2'-triethylsilyl-7,10-bis(trichloroacetyl)docetaxel

[0134] At room temperature, 2'-triethylsilyl-7,10-bis(trichloroacetyl)docetaxel (10 g) was dissolved in 200 ml of methanol / tetrahydrofuran, and 24 ml of 2N aqueous ammonia solution was added dropwise. After stirring the reaction for 3 hours, the reaction was concentrated in vacuo to a small volume, then diluted with water and extracted with ethyl acetate. The extract was washed with saturated brine, dried over anhydrous sodium sulfate, concentrated to dryness under reduced pressure, and then crystallized in a mixture of ethyl acetate and n-hexane to obtain 6.2 g (94% yield).

[0135] MS (m / z): 808 (M+1). 1 HNMR (500MHz) δ1.25(3H, s), 2.14(1H, m), 2.42(2H, m), 2.46(3H, s), 2.69(1H, m), 3.97(1H, d), 4.21( 1H,d), 4.39(1H,d), 4.66(1H,d), 4.69(1H,m), 4.85(2H,s), 4.98(1H,d), 5.03(1H,m), 5.34(1H , bd), 5.51(1H, bd), 5.60(1H, dd), 5.75(1H, d), 6.27(1H, bt), 6.28(1H, s), 7.37~7.45(5...

Embodiment 3

[0136] Example 3: Preparation of 2'-(1-ethoxy)ethyl-7,10-bis(trichloroacetyl)docetaxel

[0137] Dissolve 7,10-bis(trichloroethoxycarbonyl)baccatin (III) (11g) in THF, under nitrogen protection, cool down to -65°C, add 1.5N sodium hexamethyldisilazide, and stir for 10min , a solution of 1-tert-butoxycarbonyl-3-triethylsilyloxy-4-phenyl-azetidinone in tetrahydrofuran (12 g, 50 ml) was started to be added dropwise. The temperature was raised to -50°C, and the reaction was continued for 30 minutes. Add saturated brine (300ml), extract the aqueous layer with ethyl acetate (200ml×2), wash the organic layer with water (150ml) and saturated brine (150ml), dry over anhydrous sodium sulfate, concentrate to dryness, and obtain the product by silica gel column chromatography 14g (91% yield).

[0138] MS (m / z): 1190 (M+Na). 1 HNMR (500MHz) δ1.13 (10H, m), 1.31 (4H, m), 1.36 (1H, m), 1.39 (9H, s), 1.62 (4H, m), 1.64 (1H, m), 1.75 ( 2H,m), 2.27(3H,s), 3.29(1H,m), 3.51(1H,m), 4.11(2H,m), ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an isoserine ester derivative or the salt of taxanes shown in the formula II; an R1, an R2 and an R3 in the formula are the same or different hydroxyl protecting groups. The invention further provides a preparation method for the compound and a method for further preparing an anticancer drug docetaxel according to the isoserine ester derivative. The preparation method for the compound which is high in yield and simple in steps is suitable for the industrial preparation of the docetaxel.

Description

technical field [0001] The invention relates to the fields of chemical synthesis and medicine. Specifically, the present invention relates to a novel taxane isoserine ester and a preparation method thereof, as well as a method for further preparing the antitumor drug docetaxel. Background technique [0002] Docetaxel (also known as docetaxel) is an antineoplastic drug with a structure of formula I: [0003] [0004] Formula I [0005] Docetaxel belongs to the anti-tumor drug microtubule inhibitor, and is a new anti-tumor drug obtained after structural modification on the basis of the structure of the natural anti-tumor drug paclitaxel. Compared with paclitaxel, docetaxel has stronger tumor killing effect, has killing effect on more tumor cells, faster absorption, slower elimination, and longer action time. It is a new generation of more active paclitaxel kind of derivatives. [0006] Some methods of synthesizing docetaxel are reported in the literature: [0007] Usua...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D305/14
CPCY02P20/55
Inventor 郑云满唐志军杨会春卓忠浩季晓铭刘勇何兵明许天惠姚勇徐晶
Owner SHANGHAI TECHWELL BIOPHARMACEUTICALS CO LTD